These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14730473)

  • 41. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment.
    Merli GJ
    J Thromb Thrombolysis; 2004 Oct; 18(2):117-25. PubMed ID: 15789178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
    Lee AY
    J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 45. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer related thrombophilia: clinical importance and management strategies.
    Gupta PK; Charan VD; Kumar H
    J Assoc Physicians India; 2005 Oct; 53():877-82. PubMed ID: 16459532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 50. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
    Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
    Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A; Iannucci A; Dager WE
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of low-molecular-weight heparins in patients with prosthetic heart valves].
    Hering D; Horstkotte D
    Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904
    [No Abstract]   [Full Text] [Related]  

  • 58. Heparin and low-molecular weight heparins in thrombosis and beyond.
    Mousa SA
    Methods Mol Biol; 2010; 663():109-32. PubMed ID: 20617415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low molecular weight heparins could be important in cancer.
    Siragusa S
    BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841
    [No Abstract]   [Full Text] [Related]  

  • 60. [New heparins--does it change prevention and treatment of venous thrombosis?].
    Ikkala E; Myllylä G
    Duodecim; 1993; 109(20):1753-9. PubMed ID: 7736998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.